These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27470553)

  • 1. Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma.
    Liu L; Qi XJ; Zhong ZK; Zhang EN
    Biomed Pharmacother; 2016 Oct; 83():79-84. PubMed ID: 27470553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma.
    Qin YG; Zhu LY; Wang CY; Zhang BY; Wang QY; Li RY; Liu Z
    Lipids Health Dis; 2015 Jul; 14():70. PubMed ID: 26170203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid.
    Yao J; Li Y; Sun X; Dahmani FZ; Liu H; Zhou J
    Int J Nanomedicine; 2014; 9():3313-24. PubMed ID: 25045262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A solvent-assisted active loading technology to prepare gambogic acid and all-trans retinoic acid co-encapsulated liposomes for synergistic anticancer therapy.
    Na K; Liu K; Yu J; Wang X; Li M; Tian C; He H; He Y; Wang Y
    Drug Deliv Transl Res; 2020 Feb; 10(1):146-158. PubMed ID: 31529371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy.
    Ding Y; Wang Y; Opoku-Damoah Y; Wang C; Shen L; Yin L; Zhou J
    Biomaterials; 2015 Dec; 72():90-103. PubMed ID: 26344366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrest.
    Zhao W; Zhou SF; Zhang ZP; Xu GP; Li XB; Yan JL
    Oncol Rep; 2011 May; 25(5):1289-95. PubMed ID: 21331449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
    Li S; Xiong Y; Zhang X
    Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma.
    Chen B; Yang JZ; Wang LF; Zhang YJ; Lin XJ
    BMC Cancer; 2015 Oct; 15():752. PubMed ID: 26486165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer.
    Zhang D; Chu Y; Qian H; Qian L; Shao J; Xu Q; Yu L; Li R; Zhang Q; Wu F; Liu B; Liu Q
    Int J Nanomedicine; 2020; 15():735-747. PubMed ID: 32099362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance.
    Wang S; Yang Y; Wang Y; Chen M
    Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment.
    Zhang Z; Qian H; Yang M; Li R; Hu J; Li L; Yu L; Liu B; Qian X
    Int J Nanomedicine; 2017; 12():1593-1605. PubMed ID: 28280328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiple environment-sensitive prodrug nanomicelle strategy based on chitosan graftomer for enhanced tumor therapy of gambogic acid.
    Du Q; Lv F; Huang J; Tang X; Zhao Z; Chen J
    Carbohydr Polym; 2021 Sep; 267():118229. PubMed ID: 34119182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved druggability of gambogic acid using core-shell nanoparticles.
    Liu F; Huang X; Han L; Sang M; Hu L; Liu B; Duan B; Jiang P; Wang X; Qiao Z; Ma C; Liu W; Liu J; Feng F; Qu W
    Biomater Sci; 2019 Feb; 7(3):1028-1042. PubMed ID: 30608065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-542-3p Appended Sorafenib/All-trans Retinoic Acid (ATRA)-Loaded Lipid Nanoparticles to Enhance the Anticancer Efficacy in Gastric Cancers.
    Li T; Zhang Y; Meng YP; Bo LS; Ke WB
    Pharm Res; 2017 Dec; 34(12):2710-2719. PubMed ID: 29181687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma.
    Duan R; Li C; Wang F; Yangi JC
    Colloids Surf B Biointerfaces; 2017 Nov; 159():880-887. PubMed ID: 28892872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion.
    Yu F; He C; Waddad AY; Munyendo WL; Lv H; Zhou J; Zhang Q
    Drug Dev Ind Pharm; 2014 Jun; 40(6):774-82. PubMed ID: 23679668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery.
    Zhang ZH; Wang XP; Ayman WY; Munyendo WL; Lv HX; Zhou JP
    Drug Deliv; 2013 Feb; 20(2):86-93. PubMed ID: 23495734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin-conjugated polymeric nanomedicine to enhance the anticancer efficacy of edelfosine in acute myeloid leukemia.
    Sun Y; Sun ZL
    Biomed Pharmacother; 2016 Oct; 83():51-57. PubMed ID: 27470549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles.
    Wang C; Zhang H; Chen B; Yin H; Wang W
    Int J Nanomedicine; 2011; 6():1929-35. PubMed ID: 21931488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gambogic acid-loaded electrosprayed particles for site-specific treatment of hepatocellular carcinoma.
    Yin D; Yang Y; Cai H; Wang F; Peng D; He L
    Mol Pharm; 2014 Nov; 11(11):4107-17. PubMed ID: 25290462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.